Social Media Ideas for Glenmark Pharma

Glenmark launches generic Olanzapine injection in US

Glenmark Shifts to High-Margin Proprietary Space with Historic European Launch of Winlevi Acne Cream

Synopsis: Glenmark Pharmaceuticals has launched Winlevi® (clascoterone 10 mg/g cream) across key European markets for the treatment of acne vulgaris. The launch marks Glenmark’s fi...

Glenmark Pharma Share: How Will the ₹19,000 Cr AbbVie Deal Benefit the Company?

Synopsis: The share of this pharmaceutical company remains supported by strong growth guidance, improving global business momentum, and a Rs 19,000 crore AbbVie deal that could unl...

Granules India gets First-To-File status for generic Lumryz tablets in US

This was Granules’ second Sole First-to-File ANDA, following its earlier approval for Amphetamine Extended-Release Tablets,

Sun Pharma to acquire Innovcare Lifesciences in ₹271 crore deal

Gland Pharma: What should you do?

Margin improvement from higher value-added products and expanding portfolio should support earnings growth

IPCA Labs, Biocon, Laurus Labs, Gland Pharma, Aurobindo, Sun Pharma shares hit 52-week highs; what's next?

Other pharma stocks, including Wockhardt Ltd, Lupin Ltd, Divi's Laboratories Ltd, Zydus Lifesciences Ltd, Torrent Pharmaceuticals Ltd, JB Chemicals & Pharmaceuticals Ltd, Manki...

Gland Pharma, Sun Pharmaceutical, Laurus Labs shares zoom up to 16% to hit 52-week highs; here's why

Gland Pharma jumped 15.85 per cent to Rs 2,164.40, while Sun Pharma climbed 1 per cent to Rs 1,896.90. Laurus Labs moved up 0.63 per cent to Rs 1,332.

Merck launches GCC in Bengaluru

Merck’s Bengaluru GCC to bring together approximately 3,300 professionals

Marksans Pharma acquires German OTC distributor ABCnow GmbH for €892,384

The acquisition gives Marksans direct front-end sales and distribution infrastructure in Germany, which will be used for marketing products manufactured across its India, UK, and U...

July 15 2026 - Sun Pharma wins South Africa approval to launch generic Ozempic

July 15 2026 - Sun Pharma wins South Africa approval to launch generic Ozempic admin Wed, 07/15/2026 - 12:37 Innovation remained front and center today, with progre...

GVRP, StepsBio set up CoE for formulations R&D in Bengaluru

GSRC is designed to tackle complex formulation challenges by combining advanced scientific infrastructure with specialised workflows for drug delivery systems, sterile injectables,...

After early Semaglutide lead, Torrent Pharma eyes US liver drug Resmetirom for India launch

Resmetirom is the first approved therapy in the US specifically for MASH, earlier known as NASH—a progressive fatty liver disease linked to obesity, diabetes and poor metabolic hea...

Dr Reddy's shares slide 7% after delay in semaglutide supplies over quality concerns

Dr Reddy's shares fell sharply on Thursday after the company delayed commercial supplies of its semaglutide product due to a quality issue involving the active pharmaceutical ingre...

Pharma Stocks In Focus: Semaglutide Opportunities And Revlimid Challenges

The pharmaceutical sector continues to offer opportunities. Business Today TV’s Shailendra Bhatnagar discussed with Vaibhav Sanghavi, CEO of ASK Hedge Solutions, that investors sh...

5 Indian CDMO Stocks Benefiting from the Global Pharma Outsourcing Boom

Synopsis: Global pharmaceutical companies are rapidly diversifying their manufacturing supply chains as geopolitical tensions, regulatory changes and the proposed U.S. BIOSECURE Ac...

Bliss GVS Pharma Rallies 45% in 10 Sessions Via The Anupam Rasayan Deal and Two Other Catalysts

Synopsis: A rare convergence of a Rs. 2,198 crore control-change acquisition by Anupam Rasayan India, a fresh WHO-GMP certification for its Palghar manufacturing unit, and a 129 pe...

<![CDATA[GSK Enters $10.6 Billion Agreement to Acquire Nuvalent Inc. ]]>

Pharma Stock Jumps After Securing ₹515 Cr Contracts from Malaysia’s Ministry of Health

Synopsis: Biocon strengthened its Malaysia presence after partner Duopharma secured insulin contracts worth over ₹514 crore, supporting affordable diabetes treatment and expanding...

India's Dr Reddy's on track for worst day in 3 years as semaglutide supplies hit

Wockhardt to go solo in marketing its USFDA approved novel antibiotic

US approval for Zaynich (cefepime and zidebactam) marks a first for a locally developed new chemical entity

Dr Reddy’s launches Bosutinib tablets in US market

The company has collaborated with MSN Laboratories on the product

Pharma Stock Jumps 10% After Securing Japanese Patent for Cancer Treatment Compound

Synopsis: Shares surged 10% after the company secured a Japanese patent for a novel cancer-treatment compound. The patent covers compounds effective against cancer and cancer stem...

Here's how this Indian company's antibiotic became the first to receive US FDA

Wockhardt is betting big on a space the world's largest pharmaceutical companies have abandoned.